ABACAVIR 300 MG TABLET

Abacavir
$0.6586per EA

Strength

300 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097051403

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ABACAVIR SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078119

On Market Since

11/21/2017

Pharmacological Classes

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors

Price History

1W

0.0%

1M

+1.0%

3M

+4.4%

6M

+2.1%

1Y

+3.5%

3Y

+10.4%

5Y

-13.1%

All

-42.8%